Immunological serotype interactions and their effect on the epidemiological pattern of dengue
暂无分享,去创建一个
Mario Recker | Konstantin B. Blyuss | Cameron P. Simmons | Tran Tinh Hien | J. Farrar | Sunetra Gupta | T. Hien | K. Blyuss | C. Simmons | M. Recker | B. Wills | Jeremy Farrar | Bridget Wills | Sunetra Gupta
[1] Bob W. Kooi,et al. Epidemiology of Dengue Fever: A Model with Temporary Cross-Immunity and Possible Secondary Infection Shows Bifurcations and Chaotic Behaviour in Wide Parameter Regions , 2008 .
[2] Katia Koelle,et al. Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever , 2008, Proceedings of the National Academy of Sciences.
[3] A. Nisalak,et al. A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.
[4] Ira B Schwartz,et al. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] N. Ferguson,et al. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] Alan L Rothman,et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. , 2004, The Journal of infectious diseases.
[7] Donald S Burke,et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. , 2003, The American journal of tropical medicine and hygiene.
[8] J. Farrar,et al. Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. , 2008, The Journal of infectious diseases.
[9] Pejman Rohani,et al. Ecological and immunological determinants of dengue epidemics. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Edelman. Dengue vaccines approach the finish line. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] M. St. Claire,et al. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention , 2007, Proceedings of the National Academy of Sciences.
[12] M. Aye,et al. Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.
[13] A. Nisalak,et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.
[14] A. Rothman,et al. Immunopathogenesis of Dengue hemorrhagic fever. , 1999, Virology.
[15] Ira B Schwartz,et al. Chaotic desynchronization of multistrain diseases. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.
[16] A. Nisalak,et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.
[17] N. Karabatsos,et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.
[18] E. C. Holmes,et al. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok , 2006, Proceedings of the National Academy of Sciences.
[19] Akira Sasaki,et al. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[20] Mario Recker,et al. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types , 2007, Proceedings of the National Academy of Sciences.
[21] P. Puthavathana,et al. Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection , 2008, Journal of Virology.
[22] D. Gubler. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.
[23] Y. Kawaoka,et al. Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications , 2003, Reviews in medical virology.
[24] S. Halstead,et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.
[25] Charles H. Hoke,et al. SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999 , 2003 .
[26] C. King,et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] S. Halstead. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.
[28] Richard G Jarman,et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. , 2007, The American journal of tropical medicine and hygiene.
[29] I. Kurane,et al. Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002 , 2005, Epidemiology and Infection.